tiprankstipranks
Inmune Bio Inc (INMB)
NASDAQ:INMB
US Market

Inmune Bio (INMB) Income Statement

Compare
703 Followers

Inmune Bio Income Statement

Last quarter (Q3 2024), Inmune Bio's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Inmune Bio's net income was $-12.09M. See Inmune Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 155.00K$ 374.00K$ 181.00K$ 10.92K$ 77.69M
Gross Profit
$ 155.00K$ 374.00K$ 181.00K$ 10.92K$ 77.69M
Operating Expenses
$ 29.90M$ 26.32M$ 29.33M$ 12.24M$ 9.30M
Depreciation and Amortization
$ 0.00$ 25.95M$ 29.15M$ 12.23M$ 9.30M
EBITDA
$ -29.74M$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income
$ -29.74M$ -25.95M$ -29.15M$ -12.23M$ -7.76M
Other Income/Expenses
$ -267.00K$ -1.35M$ -1.19M$ 129.00K$ 77.69K
Pretax Income
$ -30.01M$ -27.30M$ -30.34M$ -12.10M$ -7.68M
Net Income
$ -30.01M$ -28.65M$ -30.34M$ -12.10M$ -9.14M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.67$ -1.60$ -1.88$ -1.01$ -0.89
Diluted EPS
$ -1.67$ -1.60$ -1.88$ -1.01$ -0.89
Weighted Average Shares Outstanding
17.98M 17.93M 16.13M 11.99M 10.27M
Weighted Average Shares Outstanding (Diluted)
17.98M 17.93M 16.13M 11.99M 10.27M
Currency in USD

Inmune Bio Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis